Abstract
Cyclic guanosine monophosphate (cGMP) plays a key role in cardiorenal protection. After activation of guanylyl cyclase receptor A (GC-A) by atrial natriuretic peptide (ANP) and b-type natriuretic peptide (BNP), plasma and urinary cGMP increases. To date, plasma and urinary cGMP in human heart
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
